-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $49

Benzinga·10/29/2026 14:05:54
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $46 to $49.